CHINA SXT PHARMACEUTICALS IN's ticker is SXTC and the CUSIP is G2161P108. A total of 7 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $18,000 | -45.5% | 55,184 | -59.5% | 0.00% | – |
Q3 2020 | $33,000 | -50.0% | 136,125 | +9.1% | 0.00% | – |
Q2 2020 | $66,000 | +500.0% | 124,770 | +523.8% | 0.00% | – |
Q1 2020 | $11,000 | – | 20,000 | +199900.0% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 10 | -99.5% | 0.00% | – |
Q2 2019 | $7,000 | -53.3% | 1,971 | -10.9% | 0.00% | – |
Q1 2019 | $15,000 | – | 2,211 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hudock, Inc. | 7,500 | $2,000 | 0.00% |
UBS Group AG | 55,184 | $18,000 | 0.00% |
FIFTH THIRD BANCORP | 1,000 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 106,568 | $35,000 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 36,886 | $12,000 | 0.00% |
Renaissance Technologies | 664,647 | $218,000 | 0.00% |